JP2022024034A5 - - Google Patents

Download PDF

Info

Publication number
JP2022024034A5
JP2022024034A5 JP2021183553A JP2021183553A JP2022024034A5 JP 2022024034 A5 JP2022024034 A5 JP 2022024034A5 JP 2021183553 A JP2021183553 A JP 2021183553A JP 2021183553 A JP2021183553 A JP 2021183553A JP 2022024034 A5 JP2022024034 A5 JP 2022024034A5
Authority
JP
Japan
Prior art keywords
drawings
present application
invention described
application
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021183553A
Other languages
English (en)
Japanese (ja)
Other versions
JP7652682B2 (ja
JP2022024034A (ja
Filing date
Publication date
Priority claimed from JP2020562542A external-priority patent/JP6977185B2/ja
Application filed filed Critical
Publication of JP2022024034A publication Critical patent/JP2022024034A/ja
Publication of JP2022024034A5 publication Critical patent/JP2022024034A5/ja
Priority to JP2025041552A priority Critical patent/JP2025085744A/ja
Application granted granted Critical
Publication of JP7652682B2 publication Critical patent/JP7652682B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021183553A 2018-12-28 2021-11-10 ピロリジン化合物の結晶 Active JP7652682B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025041552A JP2025085744A (ja) 2018-12-28 2025-03-14 ピロリジン化合物の結晶

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2018247437 2018-12-28
JP2018247437 2018-12-28
JP2020562542A JP6977185B2 (ja) 2018-12-28 2019-12-27 ピロリジン化合物の結晶
PCT/JP2019/051570 WO2020138481A1 (ja) 2018-12-28 2019-12-27 ピロリジン化合物の結晶

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020562542A Division JP6977185B2 (ja) 2018-12-28 2019-12-27 ピロリジン化合物の結晶

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025041552A Division JP2025085744A (ja) 2018-12-28 2025-03-14 ピロリジン化合物の結晶

Publications (3)

Publication Number Publication Date
JP2022024034A JP2022024034A (ja) 2022-02-08
JP2022024034A5 true JP2022024034A5 (enExample) 2023-01-10
JP7652682B2 JP7652682B2 (ja) 2025-03-27

Family

ID=71127176

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020562542A Active JP6977185B2 (ja) 2018-12-28 2019-12-27 ピロリジン化合物の結晶
JP2021183553A Active JP7652682B2 (ja) 2018-12-28 2021-11-10 ピロリジン化合物の結晶
JP2025041552A Pending JP2025085744A (ja) 2018-12-28 2025-03-14 ピロリジン化合物の結晶

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2020562542A Active JP6977185B2 (ja) 2018-12-28 2019-12-27 ピロリジン化合物の結晶

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025041552A Pending JP2025085744A (ja) 2018-12-28 2025-03-14 ピロリジン化合物の結晶

Country Status (8)

Country Link
US (2) US12077524B2 (enExample)
EP (3) EP4603143A3 (enExample)
JP (3) JP6977185B2 (enExample)
CN (3) CN113226314B (enExample)
ES (1) ES2991904T3 (enExample)
MA (1) MA54619A (enExample)
TW (3) TWI834791B (enExample)
WO (1) WO2020138481A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI882128B (zh) * 2020-06-10 2025-05-01 日商田邊三菱製藥股份有限公司 紫質症之預防或治療劑
BR112022025115A2 (pt) 2020-06-10 2023-02-07 Mitsubishi Tanabe Pharma Corp Agente profilático ou terapêutico para fotodermatose
JP6959478B1 (ja) * 2020-06-10 2021-11-02 田辺三菱製薬株式会社 ポルフィリン症の予防又は治療剤
EP4317150A4 (en) * 2021-05-06 2024-10-30 Lg Chem, Ltd. CRYSTAL FORM VII OF A MELANOCORTIN RECEPTOR AGONIST COMPOUND AND METHOD FOR THE PREPARATION THEREOF
KR102854595B1 (ko) * 2021-05-06 2025-09-03 주식회사 엘지화학 멜라노코르틴 수용체 작용제 화합물의 결정형 v 및 이의 제조방법
MX2023013128A (es) * 2021-05-07 2023-11-28 Lg Chemical Ltd Cristales de sulfato de compuesto agonista del receptor de melanocortina, y metodo para producir los mismos.
CA3217468A1 (en) * 2021-05-07 2022-11-10 Lg Chem, Ltd. Crystal form iv of organic acid salts of melanocortin receptor agonist compound, and preparation method thereof
JP2024516739A (ja) * 2021-05-07 2024-04-16 エルジー・ケム・リミテッド メラノコルチン受容体アゴニスト化合物とバニリンの共結晶およびその製造方法
EP4473967A4 (en) 2022-01-31 2025-10-08 Mitsubishi Tanabe Pharma Corp NOVEL USE OF A MELANOCORTIN-1 RECEPTOR AGONIST
JP7527582B2 (ja) * 2022-08-03 2024-08-05 田辺三菱製薬株式会社 1-{2-[(3s,4r)-1-{[(3r,4r)-1-シクロペンチル-3-フルオロ-4-(4-メトキシフェニル)ピロリジン-3-イル]カルボニル}-4-(メトキシメチル)ピロリジン-3-イル]-5-(トリフルオロメチル)フェニル}ピペリジン-4-カルボン酸もしくはその医薬的に許容し得る塩又は共結晶を含有する医薬組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006030925A1 (ja) * 2004-09-13 2006-03-23 Ono Pharmaceutical Co., Ltd. 含窒素複素環誘導体およびそれらを有効成分とする薬剤
JP2009510134A (ja) * 2005-10-07 2009-03-12 ワラタ ファーマシューティカルズ, インコーポレイテッド Dpp−iv阻害剤およびガストリン化合物の組み合わせ使用
US9981960B2 (en) * 2014-05-29 2018-05-29 Mitsubishi Tanabe Pharma Corporation Pyrrolidine compound and application as melanocortin receptor agonist
JP6392297B2 (ja) 2015-11-27 2018-09-19 田辺三菱製薬株式会社 医薬組成物

Similar Documents

Publication Publication Date Title
JP2023115329A5 (enExample)
JP2021184963A5 (enExample)
JP2025027013A5 (enExample)
JP2023171775A5 (enExample)
JP2022184985A5 (enExample)
JP2022024034A5 (enExample)
JP2023166402A5 (enExample)
JP2022028828A5 (enExample)
JP2022025124A5 (enExample)
JP2021185136A5 (enExample)
JP2020010717A5 (enExample)
JP2021500894A5 (enExample)
JP2021503478A5 (enExample)
JP2023145572A5 (enExample)
JP2021038271A5 (enExample)
JP2020127428A5 (enExample)
JP2019142968A5 (enExample)
JPWO2021188969A5 (enExample)
JP2025011142A5 (enExample)
JP2023181322A5 (enExample)
JP2024045126A5 (enExample)
JP2020120660A5 (enExample)
JP2022064180A5 (enExample)
JP2020079331A5 (enExample)
JP2021008510A5 (enExample)